| Comprehensive molecular portraits of human breast tumours. CGA Network Nature 490, 61-70, 2012 | 11033* | 2012 |
| Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5090 | 2014 |
| Comprehensive genomic characterization of head and neck squamous cell carcinomas Cancer Genome Atlas Network Nature 517 (7536), 576, 2015 | 3209 | 2015 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2657 | 2015 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 675 | 2017 |
| Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma JJ Wallin, JC Bendell, R Funke, M Sznol, K Korski, S Jones, G Hernandez, ... Nature communications 7 (1), 1-8, 2016 | 633 | 2016 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 604 | 2017 |
| Characterization of HPV and host genome interactions in primary head and neck cancers M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ... Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014 | 415 | 2014 |
| The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... Journal for immunotherapy of cancer 8 (1), 2020 | 186 | 2020 |
| The molecular basis of breast cancer pathological phenotypes YJ Heng, SC Lester, GMK Tse, RE Factor, KH Allison, LC Collins, ... The Journal of pathology 241 (3), 375-391, 2017 | 119 | 2017 |
| Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations PJ Wysocki, K Korski, K Lamperska, J Zaluski, A Mackiewicz Journal of Clinical Oncology 26 (15_suppl), 1079-1079, 2008 | 74 | 2008 |
| TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development P Czerwińska, PK Shah, K Tomczak, M Klimczak, S Mazurek, B Sozańska, ... Oncotarget 8 (1), 863, 2017 | 60 | 2017 |
| Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients JP Machiels, C Gomez-Roca, JM Michot, D Zamarin, T Mitchell, G Catala, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 48 | 2020 |
| rs12976445 variant in the pri‑miR‑125a correlates with a lower level of hsa‑miR‑125a and ERBB2 overexpression in breast cancer patients TP Lehmann, K Korski, M Ibbs, P Zawierucha, S Grodecka‑Gazdecka, ... Oncology letters 5 (2), 569-573, 2013 | 46 | 2013 |
| Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer? A Markowska, M Pawałowska, V Filas, K Korski, M Gryboś, S Sajdak, ... Diabetology & metabolic syndrome 5, 1-11, 2013 | 44 | 2013 |
| Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade C Gomez-Roca, P Cassier, D Zamarin, JP Machiels, JLP Gracia, FS Hodi, ... Journal for immunotherapy of cancer 10 (5), 2022 | 37 | 2022 |
| Expression of stem cell marker CD44 in prostate cancer biopsies predicts cancer grade in radical prostatectomy specimens K Korski, A Malicka-Durczak, J Bręborowicz Polish Journal of Pathology 65 (4), 291-295, 2014 | 35 | 2014 |
| Breast cancer evaluation by fluorescent dot detection using combined mathematical morphology and multifractal techniques B Reljin, M Paskas, I Reljin, K Konstanty Diagnostic pathology 6, 1-6, 2011 | 28 | 2011 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 15, 2020 | 27 | 2020 |
| Relative levels of let‑7a, miR‑17, miR‑27b, miR‑125a, miR‑125b and miR‑206 as potential molecular markers to evaluate grade, receptor status and molecular type in breast cancer TP Lehmann, K Korski, R Gryczka, M Ibbs, A Thieleman, ... Molecular medicine reports 12 (3), 4692-4702, 2015 | 26 | 2015 |
Matthew IbbsHistology laboratory manager, Greater Poland Cancer CentreVerified email at wco.pl
